Usefulness of Serum as a Non-Invasive Sample for the Detection of Histoplasma capsulatum Infections: Retrospective Comparative Analysis of Different Diagnostic Techniques and Quantification of Host Biomarkers
Open Access
- 12 June 2025
- journal article
- research article
- Published by MDPI AG in Journal of Fungi
- Vol. 11 (6) , 448
Abstract
Diagnosis of histoplasmosis is challenging. A rapid, sensitive, and specific method is essential. Serum is a non-invasive and easy sample to obtain in any hospital. The diagnostic accuracy of different techniques that use serum has been evaluated. Forty-one serum samples from patients with proven or probable histoplasmosis were analyzed. Different diagnostic techniques based on the detection of antibodies (ID Fungal Antibody System), antigens (Histoplasma GM EIA and PlateliaTM Aspergillus Ag), and DNA (“in-house” real-time PCR (RT-PCR) were tested and compared. Additionally, the quantification of cytokines and biomarkers related to histoplasmosis was performed. Global results from 27 samples in which all the tests were performed showed that the sensitivity of the Histoplasma GM EIA kit was 87.5% in patients with disseminated infection and HIV as an underlying disease; in immunocompetent (IC) patients, it was 54.5%. The detection of Histoplasma spp. with the ID Fungal Antibody System was positive in 90.9% of IC and in 62.5% of HIV patients. The Platelia-Asp kit had a low performance in both groups of patients (37.5% in HIV and 9% in non-HIV), and, finally, RT-PCR was better in immunosuppressed patients (44% in HIV vs. 27% in non-HIV). The combination of diagnostic techniques increased the detection of Histoplasma infection in inmunosupressed patients. Overall, patient groups infected with H. capsulatum (Hc) showed higher IL-8, IL-6, IL-1β, TNF-α, and IL-18 median values compared to non-Hc-infected controls. The effectiveness of diagnostic techniques on serum samples is highly influenced by the patient’s clinical presentation and underlying condition. Consequently, a thorough assessment of the patient’s clinical presentation and disease phenotype is crucial in selecting the most suitable diagnostic method.Keywords
All Related Versions
Funding Information
- Instituto de Salud Carlos III (MPY 117/18, MPY 305/20, MPY 433/2021, CIBERINFECT CB21/13/00105, FI10/00464)
- National Centre for Microbiology (Instituto de Salud Carlos III) (MPY 117/18, MPY 305/20, MPY 433/2021, CIBERINFECT CB21/13/00105, FI10/00464)
- Instituto de Salud Carlos III (MPY 117/18, MPY 305/20, MPY 433/2021, CIBERINFECT CB21/13/00105, FI10/00464)
This publication has 41 references indexed in Scilit:
- HistoplasmosisInfectious Disease Clinics of North America, 2024
- Fungal biomarkers in HIV-associated disseminated histoplasmosis: a multicenter diagnostic accuracy study on the Guiana shieldInternational Journal of Infectious Diseases, 2024
- Evaluation of OIDx Histoplasma Urinary Antigen EIAMycopathologia, 2021
- Diagnosis of histoplasmosis: current status and perspectivesApplied Microbiology and Biotechnology, 2021
- Re-drawing the Maps for Endemic MycosesMycopathologia, 2020
- Nonculture Diagnostics in Fungal DiseaseInfectious Disease Clinics of North America, 2016
- HistoplasmosisInfectious Disease Clinics of North America, 2016
- Profile of cytokines in the lungs of BALB/c mice after intra-nasal infection with Histoplasma capsulatum mycelial propagulesComparative Immunology, Microbiology and Infectious Diseases, 2015
- The role of cytokines and chemokines in Histoplasma capsulatum infectionCytokine, 2012
- Platelia Aspergillus assay for diagnosis of disseminated histoplasmosisEuropean Journal of Clinical Microbiology & Infectious Diseases, 2007